The 10th edition of the International Conference in Dermatology and Aesthetics (AIDA) has focused on new developments in dermatology, including the use of biologics to treat some intractable diseases, using AI to treat dermatological diseases, and modern and safe laser and injection techniques in aesthetic medicine. On its final day, AIDA proposed that the UAE […]
M42, a global tech-enabled health powerhouse, has launched the next generation of its open-access generative AI Clinical Large Language Model (LLM), Med42, during Abu Dhabi Global Healthcare Week. Building upon the success of the initial launch, Med42 represents the next evolution in AI-driven health innovation, poised to advance healthcare AI and transform patient care, while […]
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and M42, a global tech-enabled health powerhouse, have collaborated to launch a groundbreaking initiative and strategic priority, the Abu Dhabi Biobank, with its first offering being the region’s largest hybrid cord blood bank. Reinforcing the Emirate’s position as a leading […]
Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully completed a complex heart transplant for Muhammad Al Ketbi suffering from familial cardiomyopathy. The 28-year-old Emirati patient, who had been suffering with heart disease for more than a decade, developed multi-organ failure, and was initially placed on an Extracorporeal membrane oxygenation (an external pump […]
Cleveland Clinic Abu Dhabi, part of the M42 group, marks a new milestone in treating acute cholecystitis in a 90-year-old patient with comorbidities using an advanced lumen-apposing metal stent (LAMS) technology for gallbladder drainage. This innovative adaptation of the procedure, originally designed for pancreatic fluid collection, reflects the hospital’s capabilities and agility in adopting the […]
